SAM
Stansberry Asset Management’s Caribou Biosciences CRBU Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-29,969
| Closed | -$49.1K | – | 127 |
|
|
2024
Q2 | $49.1K | Sell |
29,969
-34,368
| -53% | -$56.4K | 0.01% | 127 |
|
|
2024
Q1 | $331K | Sell |
64,337
-4,113
| -6% | -$21.1K | 0.04% | 114 |
|
|
2023
Q4 | $392K | Sell |
68,450
-8,782
| -11% | -$50.3K | 0.07% | 104 |
|
|
2023
Q3 | $369K | Buy |
77,232
+5,737
| +8% | +$27.4K | 0.06% | 103 |
|
|
2023
Q2 | $304K | Buy |
71,495
+638
| +0.9% | +$2.71K | 0.06% | 91 |
|
|
2023
Q1 | $376K | Buy |
70,857
+853
| +1% | +$4.53K | 0.07% | 93 |
|
|
2022
Q4 | $440K | Buy |
70,004
+2,342
| +3% | +$14.7K | 0.09% | 91 |
|
|
2022
Q3 | $714K | Sell |
67,662
-1,676
| -2% | -$17.7K | 0.15% | 84 |
|
|
2022
Q2 | $376K | Sell |
69,338
-23,451
| -25% | -$127K | 0.08% | 96 |
|
|
2022
Q1 | $852K | Buy |
92,789
+25,418
| +38% | +$233K | 0.14% | 90 |
|
|
2021
Q4 | $1.02M | Buy |
67,371
+40,047
| +147% | +$605K | 0.16% | 67 |
|
|
2021
Q3 | $652K | Buy |
+27,324
| New | +$652K | 0.13% | 62 |
|